Product details:
| ISBN13: | 9781009429696 |
| ISBN10: | 1009429698 |
| Binding: | Paperback |
| No. of pages: | 468 pages |
| Language: | English |
| 700 |
Category:
Handbook of Drugs in Intensive Care: Volume 1
An A-Z Guide
Edition number: 7
Publisher: Cambridge University Press
Date of Publication: 30 January 2025
Normal price:
Publisher's listprice:
GBP 29.99
GBP 29.99
Your price:
12 596 (11 996 HUF + 5% VAT )
discount is: 20% (approx 3 149 HUF off)
Discount is valid until: 31 December 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
Not yet published.
Short description:
A fully updated seventh edition of a well-established guide to drugs and prescribing for healthcare professionals working in intensive care.
Long description:
This essential guide continues to provide invaluable information on using medications safely and effectively in the intensive care setting. Split into two sections, the first being an A-Z guide to the drugs available and concise notes on the key topics and scenarios faced on a daily basis. This section provides succinct information on each drug including uses, administration directions and adverse effects. The second section details practice guidelines on areas such as drug dosing in renal failure and haemofiltration, Parkinson's disease therapy when nil-by-mouth and insulin therapy. This new edition features an array of new drug monographs alongside thorough updates to existing monographs, guidelines and the unique IV compatibility table, which allows readers to identify compatible and non-compatible drugs combinations. Presented in a concise, compact format, this book is an invaluable resource for doctors, pharmacists, nurses, advanced clinical practitioners, and other professionals caring for critically ill patients.
Table of Contents:
Introduction; How to use this book; Abbreviations; Acknowledgements; Drugs: An A-Z Guide; Prescribing using generic or brand names; Routes of administration; Loading dose; Drug metabolism; Enzyme systems; Drug excretion; Drug tolerance; Drug interactions; Therapeutic drug monitoring; Target range of concentration; Pharmacology in the critically ill; Body weight; Cardiopulmonary resuscitation; Drugs in advanced life support; Management of acute major anaphylaxis; Management of acute severe hyperkalaemia; Management of malignant hyperthermia (MH); Sedation, analgesia and neuromuscular blockade; Opioid conversion table; Antiretroviral drugs: alternatives for swallowing difficulties; Management of status epilepticus; Prevention of delirium tremens and alcohol withdrawal syndrome; Prevention of Wernicke-Korsakoff syndrome; Anti-arrhythmic drugs; Inotropes and vasopressors; Bronchospasm; Anti-ulcer drugs; Corticosteroids; Heparin induced thrombocytopaenia; NOAC/DOAC; Guidelines for patients with absent or dysfunctional spleen; Anti-microbial drugs; Bacterial gram staining; Antibiotics: sensitivities; Alterations to drug dosing in renal dysfunction and Haemo(dia)filtration; Chemical pleurodesis of malignant pleural effusion; Hyponatraemia & SIADH Diagnosis and Management; Fluoroquinolone antibiotics: new restrictions and precautions for use; Suspected sepsis; Appendix A: creatinine clearance; Appendix B: citrate based anticoagulation for renal replacement therapy; Appendix C: body mass index (BMI) calculator; Appendix D: lean body weight charts; Appendix E: estimated height from ulna length; Appendix F: infusion rate/dose calculation; Appendix G: drug compatibility chart; Appendix H: sodium content of oral medications; Appendix I: drug management of the brain-stem-dead donor; Appendix J: vancomycin by continuous infusion; Appendix K: Child-Pugh score; Appendix L: insulin guidelines; Drug index; Compatibility chart.
